Brief: Biogen Inc Says If Deal Terminated Under Certain Conditions, Reata Will Be Required To Pay Biogen Termination Fee Equal To $264 Mln
31/07/2023 12:31
July 31 (Reuters) - Biogen Inc BIIB.O :
* BIOGEN INC - WILL BE REQUIRED TO PAY REATA TERMINATION FEE
EQUAL
TO $301 MILLION IN CASE OF TERMINATION
* BIOGEN INC- IF DEAL TERMINATED UNDER CERTAIN CONDITIONS,
REATA
WILL BE REQUIRED TO PAY BIOGEN A TERMINATION FEE EQUAL TO $264
MILLION
Further company coverage: BIIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reata Pharmaceuticals
See all newsReata Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Reata Pharmaceuticals Inc expected to post a loss of $2.88 a share - Earnings Preview
Brief: Biogen Inc Says If Deal Terminated Under Certain Conditions, Reata Will Be Required To Pay Biogen Termination Fee Equal To $264 Mln
U.S. STOCKS ON THE MOVE-US regional banks, Enphase, Centene
Biogen’s $7 bln deal goes smaller and safer